Home > A. Molecular pathology > CDs > CD33


Thursday 15 December 2011


CD33 or Siglec-3 is a transmembrane receptor expressed on cells of myeloid lineage. It is usually considered myeloid-specific, but it can also be found on some lymphoid cells.

It binds sialic acids, therefore is a member of the SIGLEC family of lectins.

The extracellular portion of this receptor contains two immunoglobulin domains (one IgV and one IgC2 domain), placing CD33 within the immunoglobulin superfamily. The intracellular portion of CD33 contains immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that are implicated in inhibition of cellular activity.

Targeted therapy

CD33 is the target of gemtuzumab ozogamicin, a monoclonal antibody-based treatment for acute myeloid leukemia (AML).

See also

- CDs